HilleVax Inc./$HLVX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
Ticker
$HLVX
Sector
Primary listing
Employees
14
Headquarters
Website
HilleVax Inc. Metrics
BasicAdvanced
$103M
-
-$1.43
0.77
-
Price and volume
Market cap
$103M
Beta
0.77
52-week high
$2.17
52-week low
$1.34
Average daily volume
599K
Financial strength
Current ratio
26.394
Quick ratio
25.955
Long term debt to equity
13.471
Total debt to equity
15.926
Interest coverage (TTM)
-28.25%
Profitability
EBITDA (TTM)
-50.905
Management effectiveness
Return on assets (TTM)
-14.48%
Return on equity (TTM)
-40.31%
Valuation
Price to book
0.7
Price to tangible book (TTM)
0.7
Price to free cash flow (TTM)
-1.688
Free cash flow yield (TTM)
-59.26%
Free cash flow per share (TTM)
-1.233
Growth
Earnings per share change (TTM)
-57.87%
3-year earnings per share growth (CAGR)
-57.92%
HilleVax Inc. News
AllArticlesVideos
Shareholder Alert: The Ademi Firm Investigates Whether HilleVax, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Business Wire·1 week ago
HILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX
Business Wire·2 weeks ago
HLVX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of HilleVax, Inc. Is Fair to Shareholders
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for HilleVax Inc. stock?
HilleVax Inc. (HLVX) has a market cap of $103M as of August 18, 2025.
What is the P/E ratio for HilleVax Inc. stock?
The price to earnings (P/E) ratio for HilleVax Inc. (HLVX) stock is 0 as of August 18, 2025.
Does HilleVax Inc. stock pay dividends?
No, HilleVax Inc. (HLVX) stock does not pay dividends to its shareholders as of August 18, 2025.
When is the next HilleVax Inc. dividend payment date?
HilleVax Inc. (HLVX) stock does not pay dividends to its shareholders.
What is the beta indicator for HilleVax Inc.?
HilleVax Inc. (HLVX) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.